Edition:
United States

Exelixis Inc (EXEL.OQ)

EXEL.OQ on NASDAQ Stock Exchange Global Select Market

24.05USD
15 Jan 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$24.05
Open
$23.39
Day's High
$24.18
Day's Low
$22.71
Volume
1,585,403
Avg. Vol
1,174,716
52-wk High
$31.78
52-wk Low
$13.43

Chart for

About

Exelixis, Inc. is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. The Company's cabozantinib product is an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors. The Company's... (more)

Overall

Beta: 2.12
Market Cap(Mil.): $5,626.86
Shares Outstanding(Mil.): 298.98
Dividend: --
Yield (%): --

Financials

  EXEL.OQ Industry Sector
P/E (TTM): 15.98 95.96 30.88
EPS (TTM): 1.18 -- --
ROI: 51.38 0.60 13.80
ROE: 63.82 -2.18 15.29

Earnings vs. Estimates